13.2mg Intranasal Epinephrine Spray Demonstrates Comparable PK/PD and Safety to 0.3mg Epinephrine Autoinjector

David Dworaczyk,Allen Hunt

Journal of Allergy and Clinical Immunology（2023）

引用 1|浏览0

暂无评分

摘要

Utuly 13.2mg is a self-administered, intranasal dosage form of epinephrine intended for the treatment of type 1 allergic reactions, including anaphylaxis. The present study compares the PK/PD and safety profiles of intranasal epinephrine with epinephrine administered intramuscularly.

查看译文

关键词

intranasal epinephrine spray,comparable pk/pd

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要